Gland Pharma

GLAND03 May 2024

Pharmaceuticals

₹

-37.10 (-2.16%)

Lowest Today

Highest Today

Prev. Close

Today’s Open

52 Week High

52 Week Low

BUY

SELL

To Invest in Gland Pharma

Gland Pharma

Pharmaceuticals

GLAND03 May 2024

₹

-37.10 (-2.16%)

OverviewFundamentals

Corporate action

Peer comparison

Income Sheet

Balance sheet

Cash flow

Share holding

About Us

Corporate Action

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

All

Dividends

Bonus

Splits

Others

Ex-Date	Type	Description	Record Date
25-Mar-2024	BC	GLAND PHARMA LIMITED has informed BSE about Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent. Reason Of Change Resignation Name Mr. Prakash Vit	30-Apr-2024
29-Apr-2024	BC	Outcome of Board Meeting held on April 29, 2024 Appointment of Mr. Satnam Singh Loomba as Chief Operating Officer	29-Apr-2024
13-Apr-2024	BC	Lakumi Trust	09-Apr-2024
01-Apr-2024	BC	Trading Members of the Exchange are hereby informed that the further new securities issued by the under mentioned companies are listed and admitted for trading on the Exchange with effect from Tuesda	02-Apr-2024
27-Feb-2024	BC	Trading Members of the Exchange are hereby informed that the further new securities issued by the under mentioned companies are listed and admitted for trading on the Exchange with effect from Wednes	28-Feb-2024

No Rights has been declared by GLAND

Book Closure

Record Date	Split Date	Purpose
30-Apr-2024	-	GLAND PHARMA LIMITED has informed BSE about Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent. Reason Of Change Resignation Name Mr. Prakash Vit
29-Apr-2024	-	Outcome of Board Meeting held on April 29, 2024 Appointment of Mr. Satnam Singh Loomba as Chief Operating Officer
09-Apr-2024	-	Lakumi Trust
02-Apr-2024	-	Trading Members of the Exchange are hereby informed that the further new securities issued by the under mentioned companies are listed and admitted for trading on the Exchange with effect from Tuesda
28-Feb-2024	-	Trading Members of the Exchange are hereby informed that the further new securities issued by the under mentioned companies are listed and admitted for trading on the Exchange with effect from Wednes

Peer Comparison

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Scrip Name	Price	Daily Change	M.Cap (Cr)	1 Year Returns %	P/E (TTM)	PB Ratio
Gland Pharma Ltd ₹1,683.80(-37.10/-2.16%)	1,683.80	-37.10	28,345.03	25.02	33.92	3.38
Astrazeneca Pharma India Ltd ₹5,424.45(+90.60/1.70%)	5,424.45	+90.60	13,334.63	67.79	83.60	20.36
Bliss GVS Pharma Ltd ₹119.10(-10.10/-7.82%)	119.10	-10.10	1,352.61	67.42	19.82	1.38
Cipla Ltd ₹1,424.75(+5.20/0.37%)	1,424.75	+5.20	114,613.75	54.95	34.85	4.43
Amrutanjan Health Care Ltd ₹775.50(-11.10/-1.41%)	775.50	-11.10	2,274.11	29.81	51.68	8.68
Abbott India Ltd ₹26,144.45(-459.90/-1.73%)	26,144.45	-459.90	56,534.24	18.89	49.35	18.18

Income Sheet

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Standalone

Consolidated

Column	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22
Gross Sales	1097.86	1010.67	884.07	785.42	925.90	1048.31
Excise Duty	0.00	0.00	0.00	0.00	0.00	0.00
Net Sales	1097.86	1010.67	884.07	785.42	925.90	1048.31
Other Operating Income	0.00	0.00	0.00	0.00	0.00	0.00
Other Income	43.39	41.11	35.21	38.94	61.51	65.62
Total Income	1141.25	1051.78	919.28	824.36	987.41	1113.93
Total Expenditure	728.37	663.57	624.71	672.73	641.94	753.07
PBIDT	412.88	388.21	294.57	151.63	345.47	360.86
Interest	0.80	0.91	1.60	2.18	2.62	1.72
PBDT	412.08	387.30	292.97	149.45	342.85	359.14
Depreciation	40.33	40.24	38.98	37.54	37.61	36.67
Tax	91.35	86.58	58.88	43.20	76.08	80.65
Deferred Tax	3.60	2.95	7.53	-10.50	1.62	2.19
Reported Profit After Tax	276.81	257.53	187.58	79.21	227.54	239.63
Extra-ordinary Items	0.00	0.00	0.00	-34.67	0.00	0.00
Adjusted Profit After Extra-ordinary item	276.81	257.53	187.58	113.88	227.54	239.63

EPS (Unit Curr.)	16.81	15.64	11.39	4.81	13.82	14.55
EPS (Adj) (Unit Curr.)	16.81	15.64	11.39	4.81	13.82	14.55
Calculated EPS (Unit Curr.)	16.81	15.64	11.39	4.81	13.82	14.55
Calculated EPS (Adj) (Unit Curr.)	16.81	15.64	11.39	4.81	13.82	14.55
Calculated EPS (Ann.) (Unit Curr.)	67.23	62.54	45.56	19.24	55.26	58.20
Calculated EPS (Adj) (Ann.) (Unit Curr.)	67.23	62.54	45.56	19.24	55.26	58.20
Book Value (Unit Curr.)	0.00	0.00	0.00	0.00	0.00	0.00
Dividend (%)	0.00	0.00	0.00	0.00	0.00	0.00
Equity	16.47	16.47	16.47	16.47	16.47	16.47
Reserve & Surplus	0.00	0.00	0.00	0.00	0.00	0.00
Face Value	1.00	1.00	1.00	1.00	1.00	1.00

Public Shareholding (No. Of Shares)	0.00	0.00	0.00	0.00	0.00	0.00
Public Shareholding (% in Equity)	0.00	0.00	0.00	0.00	0.00	0.00

Pledged/Encumbered - No. of Shares	0.00	0.00	0.00	0.00	0.00	0.00
Pledged/Encumbered - % in Total Promoters Holding	0.00	0.00	0.00	0.00	0.00	0.00
Pledged/Encumbered - % in Total Equity	0.00	0.00	0.00	0.00	0.00	0.00

Non Encumbered - No. of Shares	0.00	0.00	0.00	0.00	0.00	0.00
Non Encumbered - % in Total Promoters Holding	0.00	0.00	0.00	0.00	0.00	0.00
Non Encumbered - % in Total Equity	0.00	0.00	0.00	0.00	0.00	0.00

PBIDTM(%)	37.61	38.41	33.32	19.31	37.31	34.42
PBDTM(%)	37.53	38.32	33.14	19.03	37.03	34.26
PATM(%)	25.21	25.48	21.22	10.09	24.58	22.86

Column	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22
Gross Sales	1545.16	1373.42	1208.69	785.01	938.29	1044.40
Excise Duty	0.00	0.00	0.00	0.00	0.00	0.00
Net Sales	1545.16	1373.42	1208.69	785.01	938.29	1044.40
Other Operating Income	0.00	0.00	0.00	0.00	0.00	0.00
Other Income	37.39	53.16	37.54	38.94	61.51	65.62
Total Income	1582.55	1426.58	1246.24	823.95	999.80	1110.03
Total Expenditure	1188.77	1049.35	914.74	673.05	648.72	747.55
PBIDT	393.78	377.23	331.50	150.90	351.08	362.48
Interest	5.28	6.05	4.92	2.20	2.62	1.72
PBDT	388.50	371.19	326.58	148.69	348.46	360.75
Depreciation	105.34	81.30	65.32	37.54	37.61	36.67
Minority Interest Before NP	0.00	0.00	0.00	0.00	0.00	0.00
Tax	97.45	89.04	59.09	42.97	77.28	80.65
Deferred Tax	-6.14	6.76	8.07	-10.50	1.62	2.19
Reported Profit After Tax	191.86	194.08	194.10	78.68	231.95	241.24
Minority Interest After NP	0.00	0.00	0.00	0.00	0.00	0.00
Net Profit after Minority Interest	191.86	194.08	194.10	78.68	231.95	241.24

Extra-ordinary Items	0.00	0.00	0.00	-34.64	0.00	0.00
Adjusted Profit After Extra-ordinary item	191.86	194.08	194.10	113.32	231.95	241.24

EPS (Unit Curr.)	11.65	11.78	11.79	4.78	14.08	14.65
Book Value (Unit Curr.)	0.00	0.00	0.00	0.00	0.00	0.00
Dividend (%)	0.00	0.00	0.00	0.00	0.00	0.00
Equity	16.47	16.47	16.47	16.47	16.47	16.47

Public Shareholding (Number)	0.00	0.00	0.00	0.00	0.00	0.00
Public Shareholding (%)	0.00	0.00	0.00	0.00	0.00	0.00

Pledged/Encumbered - No. of Shares	0.00	0.00	0.00	0.00	0.00	0.00
Pledged/Encumbered - % in Total Promoters Holding	0.00	0.00	0.00	0.00	0.00	0.00
Pledged/Encumbered - % in Total Equity	0.00	0.00	0.00	0.00	0.00	0.00

Non Encumbered - No. of Shares	0.00	0.00	0.00	0.00	0.00	0.00
Non Encumbered - % in Total Promoters Holding	0.00	0.00	0.00	0.00	0.00	0.00
Non Encumbered - % in Total Equity	0.00	0.00	0.00	0.00	0.00	0.00

PBIDTM(%)	25.48	27.47	27.43	19.22	37.42	34.71
PBDTM(%)	25.14	27.03	27.02	18.94	37.14	34.54
PATM(%)	12.42	14.13	16.06	10.02	24.72	23.10

Balance Sheet

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Standalone

Consolidated

Column	Mar 23	Mar 22	Mar 21	Mar 20	Mar 19	Mar 18
SOURCES OF FUNDS :
Share Capital	16.47	16.43	16.36	15.50	15.50	15.50
Reserves Total	7936.83	7141.72	5886.93	3630.74	2846.62	2394.93
Equity Share Warrants	0.00	0.00	0.00	0.00	0.00	0.00
Equity Application Money	0.00	0.08	0.00	0.00	0.00	0.00
Total Shareholders Funds	7953.30	7158.23	5903.29	3646.24	2862.12	2410.43
Secured Loans	0.00	0.00	0.00	0.00	0.00	0.00
Unsecured Loans	4.45	4.74	5.00	4.96	5.49	5.92
Total Debt	4.45	4.74	5.00	4.96	5.49	5.92
Total Liabilities	7957.75	7162.97	5908.29	3651.20	2867.61	2416.35
APPLICATION OF FUNDS :
Gross Block	2294.96	2081.32	1430.70	1347.81	1219.58	1054.45
Less : Accumulated Depreciation	724.41	579.13	476.47	379.71	290.83	211.81
Less:Impairment of Assets	0.00	0.00	0.00	0.00	0.00	0.00
Net Block	1570.55	1502.19	954.23	968.10	928.75	842.64
Lease Adjustment	0.00	0.00	0.00	0.00	0.00	0.00
Capital Work in Progress	177.22	190.75	337.81	188.47	123.16	198.88
Producing Properties	0.00	0.00	0.00	0.00	0.00	0.00
Investments	8.16	163.03	0.55	0.00	0.00	0.00
Current Assets, Loans & Advances	0.00	0.00	0.00	0.00	0.00	0.00
Inventories	1945.30	1185.67	1275.17	756.28	911.88	512.83
Sundry Debtors	862.84	1074.81	670.97	601.79	506.10	475.21
Cash and Bank	3767.00	3085.80	3005.20	1325.19	753.35	651.14
Loans and Advances	313.20	343.30	171.73	163.03	186.14	211.80
Total Current Assets	6888.34	5689.57	5123.07	2846.29	2357.46	1850.98
Less : Current Liabilities and Provisions	0.00	0.00	0.00	0.00	0.00	0.00
Current Liabilities	698.17	538.93	458.34	329.93	518.27	363.11
Provisions	31.32	42.75	53.82	28.20	13.89	15.01
Total Current Liabilities	729.49	581.68	512.16	358.13	532.15	378.12
Net Current Assets	6158.85	5107.89	4610.90	2488.15	1825.31	1472.86
Miscellaneous Expenses not written off	0.00	0.00	0.00	0.00	0.00	0.00
Deferred Tax Assets	22.71	7.65	6.02	6.05	1.63	1.29
Deferred Tax Liability	106.92	95.41	79.90	80.10	109.26	97.04
Net Deferred Tax	-84.21	-87.76	-73.88	-74.05	-107.63	-95.75
Total Assets	7830.56	6876.10	5829.61	3570.67	2769.59	2418.63
Contingent Liabilities	22.07	12.76	74.70	11.83	21.17	0.00

Cash Flow

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

PARTICULARS	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019
Cash and Cash Equivalents at Beginning of the year	311.18	491.92	169.50	236.40	372.84
Net Cash from Operating Activities	367.89	791.29	604.93	700.94	185.06
Net Cash Used In Investing Activities	1211.22	-1006.92	-1520.97	-760.97	-318.57
Net Cash Used In Financing Activities	14.92	34.90	1238.46	-6.87	-2.93
Net Inc./Dec In Cash And Cash Equivalents	1594.04	-180.73	322.42	-66.91	-136.44
Cash And Cash Equivalents At End Of The Year	1905.22	311.18	491.92	169.50	236.40

Share Holding

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Promoter Shareholding

57.86%

FII Shareholding

3.59%

DII Shareholding

25.23%

Public Shareholding

13.32%

**Promoter pledged shareholding 57.86%

About Gland Pharma Ltd

Gland Pharma Ltd is in the Pharmaceuticals sector, having a market capitalization of Rs. 28345.03 crores. It has reported a sales of Rs. 1097.86 crores and a net profit of Rs. 276.81 crores for the quarter ended December 2018. The company management includes Yiu Kwan Stanley Lau, Yiu Kwan Stanley Lau,SRINIVAS SADU,QIYU CHEN,UDO JAHANNES VETTER,C S N Murthy,ESSAJI GOOLAM VAHANVATI,Naina Lal Kidwai,Jia Ai (Allen) Zhang,Yao Fang (Gland Pharma Ltd) among others.

Chairman

Yiu Kwan Stanley Lau

Registered office

Sy No 143-148 150&151 Nr Gandi,X Roads D P Pally Dundigal,Hyderabad,Telangana,500043

FAX :91-40-30510800

Background

Incorporation Year1978

Face Value₹1

Market Lot1

How to buy Gland Pharma shares on nse?

To buy Gland Pharma shares in Motilal Oswal, you just need to open a demat account and get your KYC documents verified

What is the Gland Pharma share price today?

The Gland Pharma shares price on nse is Rs.1683.8 today.

What is the market cap of Gland Pharma shares on BSE ?

The company has a market capitalization of Rs.28345.03Cr

What is the PE & PB ratio of Gland Pharma shares ?

PE is 33.92 and PB is 3.38

What is the 52 Week High and Low of Gland Pharma shares?

Gland Pharma stock price high: Rs.2195.75 Gland Pharma stock price low: Rs.861.5

What can be the future price of Deepak Gland Pharma?

The returns of Gland Pharma stocks in the current year have been in the negative at -24.28% (YTD 17 April 2023).

Predicting what the future stock price of any company will be, including Gland Pharma, is not a science. Stock prices are subject to various market forces/factors that affect stock prices.

While it's not really possible to precisely predict the future stock price of Gland Pharma, investors can make use of different tools and techniques to evaluate the company's market trends, financials and other relevant factors to make informed decisions where investment is concerned.

How to get Deepak Gland Pharma?

You can buy Gland Pharma stock if you register with a broker like Motilal Oswal and open a demat and trading account. With these accounts, you can place a buy order with your broker and buy the stocks of Gland Pharma.

Is Deepak Gland Pharma offering bonus stocks?

Gland Pharma has issued no bonus so far.

Where can I find stock price history for Gland Pharma?

You can find the stock price history for Gland Pharma on the Motilal Oswal Research 360 portal. All you have to do is fill in the search bar with the stock you are looking for and a page will be displayed with relevant details.

At what price did stocks of Gland Pharma Ltd open today on the BSE?

Stocks of Gland Pharma Ltd opened at Rs. 1257.95 on the BSE today (17 April 2023).